Open AccessAdjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter
Author(s) -
Fink Michael K.,
Kleeberg Ulrich R.,
Bartels Stefan
Publication year - 2015
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2015-0116
Subject(s) - medicine , adjuvant , oncology , adjuvant therapy , immunotherapy , chemotherapy , hormonal therapy , adjuvant chemotherapy , cancer , breast cancer
In the subgroup of patients who suffer from metastases despite adjuvant therapy, survival after dissemination is shortened. This is partially due to an adjuvant chemotherapy‐induced resistance to previous treatment and may be similar after hormonal therapy and immunotherapy.